pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4697 |
Genomic Coordinates | chr11: 133898504 - 133898581 |
Description | Homo sapiens miR-4697 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4697-5p | |||||||||||||||||||||
Sequence | 10| AGGGGGCGCAGUCACUGACGUG |31 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NACC1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | BEND8, BTBD14B, BTBD30, NAC-1, NAC1, NECFM | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | nucleus accumbens associated 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_052876 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on NACC1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of NACC1 (miRNA target sites are highlighted) |
>NACC1|NM_052876|3'UTR 1 CCCGCCCAGCCTCCCGCGGGGCCACACACTTCCCCTCCCAACACACACACACACCTGCCATCTTGGTCATGAGCTACTGT 81 CTGTCCCTCCCCAGGACCCGCGGTGGGTGCTGCATGTTCCCGGCCCTCTGCCCCTCCTGTCCTACCCCCTTTCCCCACCG 161 AGAGCTGGGCCGGGAGAGGACCGCAGGGCAGGTGGCGTGAGGTCCGTGTTGCCTTCTTTAACACACACTCGTGCAGTGGG 241 GGAGTTCTGGCTCCCCAACCTAACCCCTAGCCGTCATCTCCACACTCACCAGGCCCACCAGGGGAGGGGGCTGGCCTGGG 321 GGTCTTGGGAAGGCCCCTCCCCAGGCCCTAGGCCACCTCGCGGAAGCCTTCAGCCTCCGCCCCTCACTGCAGCCCCTTGG 401 GACTTGAGGGGGGCCCCAGGGGTTCTCAGGACCCCTCCCACCACCTCCCAGTGCTTCCACGTCTCCAAAAGCGCCTTCCT 481 GTCACCCTCGTCTATCCCTGCGCCTGGGGGCTGGGGTAGGCGAGGCCGTGGGGACTACCCATTTTATAGCTGGGGAAACA 561 GGCTCCGAGAAATTGCACAACCGACCTCAGGTGGCCGGCAGTGGCGTGCCTGGTGCCCTTTCTCCTCTTCCGCCTCTGTT 641 GCTCCCTTTGGTCCTCTGGGGCCTCAGAGAGGCAGGTCCTAAAGGAGGGGGGGTCTCCTGGGGGCAGACCGAGGGTCTCG 721 GAGGATAGAATGAGAGGTTTCCAGGGCTGGCAGAGTGTGTGCGTGTGTGTGTGCAGAAGTTTTGCTTTCAAACAAATGAA 801 GATACAAGAGGCAGTAGGACCTGGGTTGGAACCCAGGGGAGCAGACTGGGGGGCTGTTGCCCCTCCCTCCATCTCCCCAC 881 ACCCACCCCACCCCACAGCAGGGCTCCTGGCCCCCACCCCCCTGTACATAATTTTTAAAACCTTTTTTTAGCGAATGAAA 961 TATTGAAGTATAAGATTCCTTTTATTTTTCAAACCAATGGGGCTGTGTCTATTGTCCCCCTCGGTCCCCAGGGGTGGGGG 1041 GCCTTGGAAGGCAGGGCGGTGTTGGGGGGCTGGGGGGCAGGCTGAATGTGTGTGTGTGGGTGTGTATGTGTGGAGTGTGT 1121 GTGTGTGTTTCCATGGTAGGACTCCAGTCCCAGCTGCTGCCTAGGCTCCTGTGGGTCCTGTGGGTCCCCCTCCCCTGTTC 1201 ACCTTCCCCAACAGGGCTATAGTTTAAGGGTGTCCCAGGCCTTGGCTGGTTGGCTGGGCCCAGCTCCTGGGGGCTGGGCA 1281 GGGCAGGGCAGGGCCGGGTCCACTTCCATTGTTAGCAGTTGTTTGCAGAATTTTCTCTTTTACCATTCCTCTCTTTTTGT 1361 TCTCGCCCAGAGTGGGTGGTTTTTTGTTGTTGTTTTAGATTTTCATGTGAAGGCAGTTTTTTTTCTTTTTTAACTCCCCA 1441 TCCCCCTATGCAGGGTGTCATTTCACCATCCACATCCACATCCTTGTTTGTGTTTCTGGCCCTCGTCCTCCCTGCCTCTC 1521 ATCTGCCTCCCCAACCCCCACCTACCCACTGCTCCCAGGGGTCTCTCCAGGGGCAGGGGGATTTTAGGAGATGGGGTGGG 1601 GGCCAGCCCCTACTGGACCCTTGTAATCTGATTTGGAGACCATCCCCCCGATGGGACCAGCAGCCCCGCCGGCCCACTGG 1681 GGGTCCCTCTTAACATCTGCTTGTTGCGGGGGTCAGTCATGAGTGCCAGGGTCTGGCTGGGGTCTTGGCACTGTCTTCCT 1761 GGCCGGGGCCTGAAACCTTAGCCCCCAGCCGGCCTGAGTGGGGGATATTGACACCCCCAGCTAAAGCACAAGCACCTTAG 1841 TCACCCCTCCTCTCCCCCCGCCTCCTGGCCTGCCACCCCACCCCAGCGTTTACCCCAAAGCACAATGCCCTGGTCACTTG 1921 GCAAGCGGCTGGGCCTGACGGAGGCCGAGGGGCAGACCGGGGCTCCAGCCAGACCCCTGAAAGGAAGGTGCTCCCCCACT 2001 TCCAGGCCTTAGTTGGGGTGGGGGGGCCAGCTCCTGGGCCTGGGGTCTTCTCACCCCCACCCCCTTGTCCTGGGTAGGCC 2081 CCTGCCTGCCCCTCTCTGCCTTTTCCTCGGGTGTCCCTCCTCGAGCCCCTGTGGCATTGGCTTGGGTGGCAGAGCCCACT 2161 TGTTTCAGGGACCCCAGGAGGTGCCCCCTGGCTCCCAGGACTGTGTGTGGGTCCGGGGGGTGGGGGGGTGGGGAGAAGGG 2241 TCGGGCAGGGGGTGCAGGGGAGGAAACTCCTCACCAGGAGAGCCAAAGACAGGGTTGTGCCTTACCCCAGGAGCCACCCC 2321 TGTACCCCCCTTGCCCTGCCATTCACCCTCCACCCCTACCCCTGGGCGGCCTGCTGCTTTTTCCTTCTCTTCCTCCCCTG 2401 CCCTGAGCTGCATGGTTCCCCCACCCTGGGCAGCCAGGAAGGAATCTGAATGGAGAATCACCAACCACCAGAGAAAAAAG 2481 ACTGTGGGGCCCTCCCCTGCCAACTCCCCTTCCCTGGCCGCCCACTCAACCCACACCTCTTTCACGCAGGACAGGCTGCC 2561 CACCCTGTCCACGTGAAGTGCCAACGCCCTCCCCACCCTGGGCCGAGCCCCCACCCCTCCCTGGGCCCCCAAGTGAGATT 2641 GCACATTTAACTACTGTAAGGAGAGGAGCGGCGTTGGCAAATGTGAACCATGAGAATATCAGTGATACTGATGAGAATAA 2721 ACTAAACGCCTTTGTAACAGCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000292431.4 | 3UTR | CCCCCACCCCUCCCUGGGCCCCCAAGUGAGAUUGCACAUUUAACUACUGUAAGGAGAGGAGCGGCGUUGGCAAAUGUGAACCAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
67 hsa-miR-4697-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT441332 | C19orf26 | CACN beta subunit associated regulatory protein | 2 | 4 | ||||||||
MIRT451390 | FARSA | phenylalanyl-tRNA synthetase alpha subunit | 2 | 2 | ||||||||
MIRT452310 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT455043 | MEN1 | menin 1 | 2 | 2 | ||||||||
MIRT455256 | DDX39B | DExD-box helicase 39B | 2 | 10 | ||||||||
MIRT461279 | COX10 | COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT464945 | TXLNA | taxilin alpha | 2 | 4 | ||||||||
MIRT468043 | SIK1 | salt inducible kinase 1 | 2 | 2 | ||||||||
MIRT472523 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT472929 | MSN | moesin | 2 | 2 | ||||||||
MIRT473247 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT475828 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT478744 | CS | citrate synthase | 2 | 2 | ||||||||
MIRT480081 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT483482 | STMN3 | stathmin 3 | 2 | 4 | ||||||||
MIRT483643 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 4 | ||||||||
MIRT483721 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT484539 | BARHL1 | BarH like homeobox 1 | 2 | 6 | ||||||||
MIRT486041 | WSCD1 | WSC domain containing 1 | 2 | 4 | ||||||||
MIRT486142 | SIX5 | SIX homeobox 5 | 2 | 6 | ||||||||
MIRT486498 | MYH11 | myosin heavy chain 11 | 2 | 2 | ||||||||
MIRT486977 | STEAP3 | STEAP3 metalloreductase | 2 | 4 | ||||||||
MIRT487279 | AGPAT6 | glycerol-3-phosphate acyltransferase 4 | 2 | 4 | ||||||||
MIRT487742 | MIB2 | mindbomb E3 ubiquitin protein ligase 2 | 2 | 2 | ||||||||
MIRT487987 | RXRB | retinoid X receptor beta | 2 | 2 | ||||||||
MIRT488338 | PAX2 | paired box 2 | 2 | 2 | ||||||||
MIRT488668 | WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 2 | 4 | ||||||||
MIRT488752 | FXYD1 | FXYD domain containing ion transport regulator 1 | 2 | 2 | ||||||||
MIRT488812 | TBC1D28 | TBC1 domain family member 28 | 2 | 2 | ||||||||
MIRT489380 | RAB11B | RAB11B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT489744 | TACC3 | transforming acidic coiled-coil containing protein 3 | 2 | 2 | ||||||||
MIRT489960 | GNB2 | G protein subunit beta 2 | 2 | 2 | ||||||||
MIRT490418 | VPS51 | VPS51, GARP complex subunit | 2 | 4 | ||||||||
MIRT490639 | FEM1A | fem-1 homolog A | 2 | 2 | ||||||||
MIRT491086 | MSI1 | musashi RNA binding protein 1 | 2 | 4 | ||||||||
MIRT491298 | VGF | VGF nerve growth factor inducible | 2 | 4 | ||||||||
MIRT491366 | SLC12A5 | solute carrier family 12 member 5 | 2 | 2 | ||||||||
MIRT492464 | RASD1 | ras related dexamethasone induced 1 | 2 | 4 | ||||||||
MIRT492872 | NFIX | nuclear factor I X | 2 | 2 | ||||||||
MIRT492951 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT493704 | H2AFX | H2A histone family member X | 2 | 2 | ||||||||
MIRT493977 | EIF1 | eukaryotic translation initiation factor 1 | 2 | 4 | ||||||||
MIRT500360 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT501154 | SLC10A7 | solute carrier family 10 member 7 | 2 | 6 | ||||||||
MIRT509625 | RRP7A | ribosomal RNA processing 7 homolog A | 2 | 4 | ||||||||
MIRT512232 | ATG2A | autophagy related 2A | 2 | 8 | ||||||||
MIRT529822 | ARGFX | arginine-fifty homeobox | 2 | 4 | ||||||||
MIRT531179 | SIGLEC12 | sialic acid binding Ig like lectin 12 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT538971 | BCL7A | BCL tumor suppressor 7A | 2 | 2 | ||||||||
MIRT548357 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 2 | 4 | ||||||||
MIRT553634 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT558050 | EVI5L | ecotropic viral integration site 5 like | 2 | 2 | ||||||||
MIRT562548 | CCDC71L | coiled-coil domain containing 71 like | 2 | 4 | ||||||||
MIRT568941 | RUNX3 | runt related transcription factor 3 | 2 | 2 | ||||||||
MIRT569114 | ONECUT3 | one cut homeobox 3 | 2 | 2 | ||||||||
MIRT573591 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT619317 | ARHGAP18 | Rho GTPase activating protein 18 | 2 | 2 | ||||||||
MIRT621202 | ARPC1B | actin related protein 2/3 complex subunit 1B | 2 | 2 | ||||||||
MIRT628844 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT670497 | LYRM4 | LYR motif containing 4 | 2 | 2 | ||||||||
MIRT670545 | SHISA2 | shisa family member 2 | 2 | 2 | ||||||||
MIRT671026 | PCDHB2 | protocadherin beta 2 | 2 | 2 | ||||||||
MIRT688989 | ATP6AP1 | ATPase H+ transporting accessory protein 1 | 2 | 2 | ||||||||
MIRT709275 | MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 2 | 2 | ||||||||
MIRT715084 | ELOF1 | elongation factor 1 homolog | 2 | 2 | ||||||||
MIRT718348 | NPBWR1 | neuropeptides B and W receptor 1 | 2 | 2 | ||||||||
MIRT737406 | MMP7 | matrix metallopeptidase 7 | 2 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|